OTCBB:NMTC

Neuroone Medical Technologies Stock News

etoro logo Buy NMTC
*Your capital is at risk
$3.47
-0.0900 (-2.53%)
At Close: Jun 03, 2026
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior st
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the firm, Marke
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the
Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two busine

Best Momentum Stocks to Buy for January 6th

11:01am, Tuesday, 06'th Jan 2026
RIGL, CM and NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 2026.

New Strong Buy Stocks for January 6th

06:35am, Tuesday, 06'th Jan 2026
ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
NeuroOne Medical Technologies Corporation - Special Call Company Participants David Rosa - President, CEO & Director Ronald McClurg - Chief Financial Officer Conference Call Participants Jeffrey Cohen
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments
Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call August 14, 2025 8:30 AM ET Company Participants David A. Rosa - President, CEO & Director Ronald W.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE